Europe

---

A Swiss doctor, originally scheduled for surgery on his knee and shoulder, turned to mesenchymal stromal cell therapy and saw a remarkable 80% improvement. Thanks to this advanced treatment, he completely avoided surgery and regained full mobility—now able to do push-ups and handstands, with a significantly enhanced quality of life.

A patient from Singapore, struggling with vision loss due to chronic glaucoma, turned to Swiss Medica after surgery in Singapore could only stabilize his eye pressure, not improve his vision. Almost losing his peripheral vision, he researched stem cell therapy as a solution for regenerating his optic nerves. Encouraged by friends and medical professionals, he chose Swiss Medica. After 10 days of intensive therapy, he saw noticeable improvements in his vision and less eye redness.

Current Parkinson’s treatments only manage symptoms and do not slow the disease’s progression or prevent neuronal death. Medications often lead to side effects like involuntary movements, nausea, and hallucinations. Stem cell research offers hope by aiming to address the root cause of the disorder, potentially providing a more effective and lasting solution.